This HTML5 document contains 38 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
n9http://linked.opendata.cz/resource/drugbank/drug/DB03609/identifier/pubchem-substance/
dctermshttp://purl.org/dc/terms/
n13http://linked.opendata.cz/resource/drugbank/drug/DB03609/identifier/drugbank/
n7http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n14http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
n10http://linked.opendata.cz/resource/drugbank/drug/DB03609/identifier/pdb/
xsdhhttp://www.w3.org/2001/XMLSchema#
n12http://linked.opendata.cz/resource/drugbank/drug/DB03609/identifier/bindingdb/
n11http://linked.opendata.cz/resource/drugbank/drug/DB03609/identifier/pubchem-compound/

Statements

Subject Item
n2:DB03609
rdf:type
n3:Drug
n3:description
3-deoxyguanosine is a solid. This compound belongs to the purine nucleosides and analogues. These are compounds comprising a purine base attached to a sugar. This medication targets the protein purine nucleoside phosphorylase.
n3:group
experimental
owl:sameAs
n7:DB03609 n14:DB03609
dcterms:title
3-Deoxyguanosine
adms:identifier
n9:46508922 n10:3DG n11:6541399 n12:50144937 n13:DB03609
n3:synthesisReference
Tetsuro Fujishima, "Process for producing 3-deoxyguanosine." U.S. Patent US4594320, issued April, 1983.
n3:IUPAC-Name
n4:271B5872-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B5878-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B5877-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B5874-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B5875-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B5876-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B5870-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B586E-363D-11E5-9242-09173F13E4C5 n4:271B5871-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B586F-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B587E-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B587F-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B5879-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B587A-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B587C-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B587B-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B587D-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B5884-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B5886-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B5887-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B5883-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B5882-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B5885-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B5873-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B5880-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B5881-363D-11E5-9242-09173F13E4C5